KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.87 $1.65 Friday, 26th Apr 2024 ADAP stock ended at $1.08. This is 1.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.83% from a day low at $1.03 to a day high of $1.09.
90 days $0.730 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
Oct 30, 2020 $4.54 $4.64 $4.26 $4.51 1 152 297
Oct 29, 2020 $4.44 $4.63 $4.15 $4.53 6 768 873
Oct 28, 2020 $4.77 $4.77 $4.35 $4.40 1 691 608
Oct 27, 2020 $4.99 $4.99 $4.65 $4.78 857 957
Oct 26, 2020 $4.69 $5.12 $4.61 $4.87 1 585 319
Oct 23, 2020 $4.37 $5.16 $4.29 $4.80 3 779 045
Oct 22, 2020 $4.50 $5.18 $4.27 $4.30 3 139 165
Oct 21, 2020 $5.30 $5.38 $4.51 $4.53 2 939 485
Oct 20, 2020 $5.62 $5.73 $5.19 $5.39 2 054 469
Oct 19, 2020 $6.43 $6.54 $5.60 $5.60 2 923 641
Oct 16, 2020 $7.63 $7.70 $6.26 $6.31 4 479 359
Oct 15, 2020 $8.00 $8.21 $7.60 $7.90 1 093 008
Oct 14, 2020 $9.01 $9.18 $7.92 $7.95 1 888 203
Oct 13, 2020 $8.40 $9.31 $8.31 $9.20 1 486 154
Oct 12, 2020 $8.36 $8.64 $8.16 $8.36 336 467
Oct 09, 2020 $8.38 $8.42 $7.97 $8.21 344 700
Oct 08, 2020 $8.71 $8.86 $8.05 $8.14 439 864
Oct 07, 2020 $8.39 $8.71 $8.30 $8.66 405 929
Oct 06, 2020 $8.49 $8.61 $8.25 $8.30 295 441
Oct 05, 2020 $8.06 $8.49 $7.99 $8.46 311 147
Oct 02, 2020 $8.10 $8.68 $7.95 $8.01 314 514
Oct 01, 2020 $8.00 $8.37 $7.84 $8.36 453 951
Sep 30, 2020 $7.63 $8.32 $7.58 $7.98 567 077
Sep 29, 2020 $7.79 $8.01 $7.50 $7.66 339 861
Sep 28, 2020 $8.04 $8.13 $7.42 $7.84 477 499
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT